D-Pharm announces expected date of interim report for the DP-b99 Acute Ischemic Stroke Study, MACSI
D-Pharm Ltd., (TASE: DPRM) announced today that the interim report for the DP-b99 MACSI study is expected in February, 2012. The report will be based on the futility analysis of the data obtained from first 350 patients that complete the follow